Brello Health partners with Southend Pharmacy , a 503A compounding pharmacy

Injectable GLP-1s: Nearly 100% bioavailability Consistent, predictable absorption Doses of 1-2.4mg weekly for semaglutide FDA-Approved Oral Tablets: 0.4-1% bioavailability Requires 7-25mg doses to achieve similar effects Must be taken with specific timing and fasting requirements Compounded ODT Formulations: Theoretical bioavailability advantage over swallowed tablets Sublingual/buccal delivery bypasses stomach acid and first-pass metabolism However, research on peptide delivery shows challenges: peptides may be degraded by salivary enzymes, have poor permeability due to large molecular size, and face continuous wash-away from saliva No clinical trials have established actual bioavailability or effectiveness for compounded GLP-1 ODTs These formulations are not FDA-approved and haven't undergone rigorous testing The theoretical advantage of ODT formulations is that by dissolving in the mouth rather than the stomach, they could achieve better absorption than swallowed tablets while maintaining the convenience of a daily, needle-free option

This does not mean your body is confused
Some providers extend individual steps to six or eight weeks if side effects are significant
This can cause drooping skin on your cheeks and make you look older or more tired than you are. Beyond facial changes, common areas affected by excess skin include the upper arms, where bat wings of loose skin can develop, and the abdomen, where skin may hang in an apron-like formation
With tirzepatide's shorter 5-day half-life (vs semaglutide's 7 days), split dosing actually produces a more noticeable difference in peak-to-trough ratios